188 related articles for article (PubMed ID: 32570732)
1. Association between Five Common Plasminogen Activator Inhibitor-1 (
Oh J; An HJ; Kim JO; Jun HH; Kim WR; Kim EJ; Oh D; Kim JW; Kim NK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570732
[TBL] [Abstract][Full Text] [Related]
2. Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women.
Jeon YJ; Kim YR; Lee BE; Choi YS; Kim JH; Shin JE; Rah H; Cha SH; Lee WS; Kim NK
Thromb Haemost; 2013 Oct; 110(4):742-50. PubMed ID: 23903286
[TBL] [Abstract][Full Text] [Related]
3. Association of five common polymorphisms in the plasminogen activator inhibitor-1 gene with primary ovarian insufficiency.
Jeon YJ; Kim YR; Lee BE; Cha SH; Moon MJ; Oh D; Lee WS; Kim NK
Fertil Steril; 2014 Mar; 101(3):825-32. PubMed ID: 24355042
[TBL] [Abstract][Full Text] [Related]
4. Association between plasminogen activator inhibitor-1 gene polymorphisms and susceptibility to Parkinson's disease in Chinese patients.
Xu Q; Lai Q; Wang J; Zhuang L; Cheng L; Mo Y; Liu L; Zhao Z; Zhang Y; Weng S; Qiao S
Acta Neurol Belg; 2022 Dec; 122(6):1557-1566. PubMed ID: 34845645
[TBL] [Abstract][Full Text] [Related]
5. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
[TBL] [Abstract][Full Text] [Related]
6. Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women.
Kim JO; Han SH; Lee YH; Ahn TK; Lim JJ; Chung YS; Shin DE; Lee WS; Han IB; Kim NK
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941685
[TBL] [Abstract][Full Text] [Related]
7. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
Saidi S; Slamia LB; Mahjoub T; Ammou SB; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):153-9. PubMed ID: 17689411
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer.
Smolarz B; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B; Szewczyk T
J Exp Clin Cancer Res; 2001 Jun; 20(2):247-52. PubMed ID: 11484982
[TBL] [Abstract][Full Text] [Related]
9. Association between plasminogen activator inhibitor gene polymorphisms and osteonecrosis of the femoral head susceptibility: A case-control study.
Li Y; Liu FX; Yuan C; Meng L
Medicine (Baltimore); 2017 Oct; 96(42):e7047. PubMed ID: 29049169
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC
J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
[TBL] [Abstract][Full Text] [Related]
11. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of PAI 1 4G/5G gene polymorphism in colorectal carcinoma patients.
Halamkova J; Kiss I; Pavlovsky Z; Tomasek J; Jarkovsky J; Cech Z; Bednarova D; Tucek S; Hanakova L; Moulis M; Zavrelova J; Man M; Benda P; Robek O; Kala Z; Penka M
Neoplasma; 2013; 60(2):151-9. PubMed ID: 23259783
[TBL] [Abstract][Full Text] [Related]
14. [Association of single nucleotide polymorphisms in PAI-1 with breast cancer susceptibility and prognosis].
Chen YL; Jia YM; Xie YT; Li Y; Fang WG; Tian XX
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):533-9. PubMed ID: 27510778
[TBL] [Abstract][Full Text] [Related]
15. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.
Wang J; Peng Y; Guo H; Li C
Technol Cancer Res Treat; 2021; 20():15330338211037813. PubMed ID: 34521295
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
Kathiresan S; Gabriel SB; Yang Q; Lochner AL; Larson MG; Levy D; Tofler GH; Hirschhorn JN; O'Donnell CJ
Circulation; 2005 Sep; 112(12):1728-35. PubMed ID: 16172282
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis.
Loktionov A; Watson MA; Stebbings WS; Speakman CT; Bingham SA
Cancer Lett; 2003 Jan; 189(2):189-96. PubMed ID: 12490312
[TBL] [Abstract][Full Text] [Related]
18. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
[TBL] [Abstract][Full Text] [Related]
19. Pai-1 gene variants and COC use are associated with stroke risk: a case-control study in the Han Chinese women.
Huang X; Li Y; Huang Z; Wang C; Xu Z
J Mol Neurosci; 2014 Dec; 54(4):803-10. PubMed ID: 25231632
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease.
Onalan O; Balta G; Oto A; Kabakci G; Tokgozoglu L; Aytemir K; Altay C; Gurgey A; Nazli N
J Thromb Thrombolysis; 2008 Dec; 26(3):211-7. PubMed ID: 17721742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
